Quick Takeaways
- Fairmount Funds Management LLC filed SCHEDULE 13G/A for Astria Therapeutics, Inc. Common Stock, par value $0.001 per share (ATXS).
- Disclosed ownership: 4%.
- Date of event: 14 Oct 2025.
Fairmount Funds Management LLC - 14 Oct 2025 SCHEDULE 13G/A Report for Astria Therapeutics, Inc. Common Stock, par value $0.001 per share (ATXS)
- Filing Manager
- Fairmount Funds Management LLC
- Reporting Manager
- Fairmount Funds Management LLC
- Symbol
- ATXS
- Shares outstanding
- 59,426,225 shares
- Disclosed Ownership
- 2,377,049 shares
- Ownership
- 4%
- Form type
- SCHEDULE 13G/A
- Filing time
- 15 Oct 2025, 09:27:35 UTC
- Date of event
- 14 Oct 2025
- Previous filing
- 14 Feb 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Fairmount Funds Management LLC disclosed 4% ownership in Astria Therapeutics, Inc. Common Stock, par value $0.001 per share (ATXS) on 14 Oct 2025."
What Changed
- Previous schedule filing date: 14 Feb 2025.
- Current filing was accepted on 15 Oct 2025, 09:27.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Fairmount Funds Management LLC | 4% | 2,377,049 | 0 | 2,377,049 | /s/ Peter Harwin | Peter Harwin, Managing Member | |
| Fairmount Healthcare Fund II GP LLC | 4% | 2,377,049 | 0 | 2,377,049 | /s/ Peter Harwin | Peter Harwin, Managing Member |